The association between maternal use of antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) during pregnancy, and birth defects in newborns and infants, has been the topic of much discussion in recent years. A new study, published in the BMJ, finds a small increased risk of two SSRIs (Paxil/paroxetine and Prozac/fluoxetine) with some birth defects, but not others (including the most commonly used SSRI,
